<PAGE>
------------------------------
OMB APPROVAL
------------------------------
OMB Number 3235-0145
Expires: November 30, 1999
Estimated average burden
hours per response ..... 14.90
------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 4)(1)
Altris Software, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
022091 10 2
- --------------------------------------------------------------------------------
(CUSIP Number)
Norman L. Smith
Solomon Ward Seidenwurm & Smith, LLP
401 B Street, Suite 1200
San Diego, CA 92101
(619) 231-0303
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 21, 2000
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [_].
Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 4 Pages)
- ----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
1
<PAGE>
CUSIP No. 022091 10 2 13D Page 2 of 4 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Spescom Limited
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
WC
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
South Africa
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF 18,542,381
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 18,542,381
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
18,542,381
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
65.7%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
CO
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
2
<PAGE>
CUSIP No. 022091 10 2 13D Page 3 of 4 Pages
This Amendment No. 4 to Schedule 13D (this "Amendment No. 4") amends and
supplements the Schedule 13D filed by Spescom Limited ("Spescom") by furnishing
the information set forth below. Unless set forth below, all previous Items are
unchanged. Capitalized terms used herein which are not defined herein have the
meanings given to them in the Schedule 13D previously filed with the Securities
and Exchange Commission. Items 3 - 5 are hereby supplemented as follows:
________________________________________________________________________________
Item 3. Source and Amount of Funds or Other Consideration.
On April 21, 2000, Spescom purchased an additional 5,285,714 shares of Common
Stock of Altris Software, Inc.("Altris"), for $3.7 million. In addition,
effective April 21, 2000, $3,000,000 of Subordinated Debt and $3,000,000 of
Convertible Preferred Stock of Altris owned by Spescom, along with related
accrued interest and dividends, was converted into 9,528,096 shares of Altris
Common Stock.
The source of the funds for the purchase of the Altris Common Stock is
Spescom's working capital.
________________________________________________________________________________
Item 4. Purpose of Transaction.
Spescom acquired the Altris Common Stock as a strategic investment
due to Altris's synergistic technology, established customer base,
and established sales and support infrastructure.
As part of the transaction,
- - Altris transferred the balance of its 40% holding in Altris
Software Limited (UK)("ASL") to Spescom;
- - Spescom sold all the rights to its EMS 2000 knowledge management
software to Altris, which will be integrated with
Altris's eB technology;
- - the Altris board of directors will be reconstituted to incorporate two
Spescom representatives together with three current Altris board members;
- - ASL will retain the exclusive distribution rights for the Altris products
for all regions excluding North and South America, Mexico and the
Caribbean subject to achieving minimum annual royalty commitments.
Although the foregoing reflects activities presently contemplated by
Spescom with respect to Altris, the foregoing is subject to change at any time,
and there can be no assurance that Spescom will take any of the actions set
forth above. Except as set forth above, Spescom has no plans or proposals with
respect to any of the matters set forth in paragraphs (a) through (j) of Item 4
of Schedule 13D.
________________________________________________________________________________
Item 5. Interest in Securities of the Issuer.
Spescom will beneficially own an aggregate of 18,542,381 shares of Common Stock
of Altris, which represents approximately 65.7% of the issued and outstanding
shares of Common Stock of Altris. Spescom has the sole power to vote or to
direct the vote and the sole power to dispose or to direct the disposition of
all 18,542,381 shares of Altris Common Stock it beneficially owns.
3
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
5 May 2000
-------------------------------------------
(Date)
/S/ HILTON ISAACMAN
-------------------------------------------
(Signature)
Hilton Isaacman, Director Corporate Finance
-------------------------------------------
(Name/Title)
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
